While the psychedelic industry is facing intense growing pains, the ketamine industry has been allowed to grow, largely unchecked. How did we get here, and how does the ketamine space rebuild trust? In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley […]

The post Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry appeared first on Psychedelics Today.

Previous articlePsychedelic Investor Survey Q3 2024
Next articleSex and Psychedelics: Healing Through Altered States